- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neurochemical changes in animal models of Parkinson’s disease ; volume:8 ; number:1 ; day:13 ; month:9 ; year:2013 ; pages:1 ; date:9.2013
Molecular neurodegeneration ; 8, Heft 1 (13.9.2013), 1, 9.2013
- Urheber
-
Baranyi, Mária
- Beteiligte Personen und Organisationen
-
Milusheva, Elisaveta
Sperlágh, Beáta
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-8-S1-P7
- URN
-
urn:nbn:de:1111-2016073073010
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baranyi, Mária
- Milusheva, Elisaveta
- Sperlágh, Beáta
- SpringerLink (Online service)
Ähnliche Objekte (12)
White matter changes in Parkinson’s disease
Microbiome changes: an indicator of Parkinson’s disease?
Changes in oligodendroglial subpopulations in Parkinson’s disease
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease
Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
Investigation of monoacyglycerol lipase inhibition for disease modification in animal models of Parkinson’s disease: behavioural, neurochemical and histological investigations as well as biomarker evaluation
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
Retinal functional and structural changes in patients with Parkinson’s disease
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
White matter changes in Parkinson’s disease
Microbiome changes: an indicator of Parkinson’s disease?
Changes in oligodendroglial subpopulations in Parkinson’s disease
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease
Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
Investigation of monoacyglycerol lipase inhibition for disease modification in animal models of Parkinson’s disease: behavioural, neurochemical and histological investigations as well as biomarker evaluation
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
Retinal functional and structural changes in patients with Parkinson’s disease
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
White matter changes in Parkinson’s disease
Microbiome changes: an indicator of Parkinson’s disease?
Changes in oligodendroglial subpopulations in Parkinson’s disease
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease
Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
Investigation of monoacyglycerol lipase inhibition for disease modification in animal models of Parkinson’s disease: behavioural, neurochemical and histological investigations as well as biomarker evaluation
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
Retinal functional and structural changes in patients with Parkinson’s disease
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease